IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis

Dupilumab is a fully human antibody to interleukin-4 receptor α that improves the signs and symptoms of moderate to severe atopic dermatitis (AD). To determine the effects of dupilumab on Staphylococcus aureus colonization and microbial diversity on the skin, bacterial DNA was analyzed from swabs co...

Descripción completa

Detalles Bibliográficos
Autores principales: Callewaert, Chris, Nakatsuji, Teruaki, Knight, Rob, Kosciolek, Tomasz, Vrbanac, Alison, Kotol, Paul, Ardeleanu, Marius, Hultsch, Thomas, Guttman-Yassky, Emma, Bissonnette, Robert, Silverberg, Jonathan I., Krueger, James, Menter, Alan, Graham, Neil M.H., Pirozzi, Gianluca, Hamilton, Jennifer D., Gallo, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163930/
https://www.ncbi.nlm.nih.gov/pubmed/31252032
http://dx.doi.org/10.1016/j.jid.2019.05.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163930/
https://www.ncbi.nlm.nih.gov/pubmed/31252032
http://dx.doi.org/10.1016/j.jid.2019.05.024

Ejemplares similares